companies / cognitotx-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-19 json
| total_raised | 314,500,000314.5M | ○ |
|---|---|---|
| founded | 2016 | |
| hq | Cambridge, USA | |
| industry | unknown | |
| stage | series-b+ |
Cognito Therapeutics' Spectris is a non-invasive headset that uses audiovisual stimulation to evoke gamma brain wave activity in Alzheimer's patients. It targets people with cognitive decline who use it one hour daily at home. The device holds FDA Breakthrough Device Designation, a non-pharmaceutical approach to slowing neurodegeneration.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2026-03-01 | series-d+ | 105,000,000105.0M | null | ○ |
Cloudflare, AitThemes, Lenis 1.0.29, Unpkg, Google Tag Manager, jsDelivr, DoubleClick Floodlight, cdnjs, Webflow, WordPress, PHP, MySQL
| fact | status | src |
|---|---|---|
| Series D+, $105.0M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |